Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 901–1,000 of 1,000
Yin, L., Zhang, L., Li, L., Liu, M., Zheng, J., Xu, A., Lyu, Q., Feng, Y., Guo, Z., Ma, H., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13467 · Cited by 2
Obesity and Breast Cancer: Do Age, Race and Subtype Matter?
Arnold, K. M., Flynn, N. J., & Sims‐Mourtada, J. (2016) · PubMed · Cited by 2
Fracture risk in breast cancer: Does obesity have an effect? A scoping review
Duong, H., & Maugham, M. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100449 · Cited by 2
“Obese women are observed to have 41 % higher risk of all-cause mortality and 35 % breast cancer specific mortality [8].”
BackgroundÖzveren, A., Donger, M. R., Motor, S., & Bulut, G. (2023) · Integrative Cancer Therapies · doi:10.1177/15347354231165938 · Cited by 2
Nyrop, K. A., Kelly, E. A., Teal, R., Muss, H. B., & Charlot, M. (2023) · Cancer · doi:10.1002/cncr.34591 · Cited by 2
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast Cancer
Ishizuka, Y., Horimoto, Y., Morita, M., Kawamura, Y., Sekine, K., Obayashi, S., Kojima, Y., Tokuda, E., Higuchi, T., & Shimomura, A. (2023) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10272 · Cited by 2
“A higher recurrence rate and worse mortality have also been reported in underweight patients with breast cancer (14, 23).”
BackgroundHaemmerle, R. J., & Jatoi, A. (2023) · JCO Oncology Practice · doi:10.1200/op.23.00480 · Cited by 2
A critical review on: Comprehending breast cancer in men with reference to female
Vasudev, V. A., Mutthuraj, D., Aruna, G. L., & Basalingappa, K. M. (2024) · National Journal of Pharmaceutical Sciences · doi:10.22271/27889262.2024.v4.i1a.93 · Cited by 2
“A diet high in fruits, vegetables, seafood, legumes, oils, and vegetable oils lowers the risk of breast cancer, according to this comprehensive review [53] .”
BackgroundVaz-Gonçalves, L., Protani, M. M., Saunus, J. M., Colditz, G. A., & Reeves, M. M. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07538-w · Cited by 2
“5, 6, and 7 show the pooled analyses for these studies.”
Low albumin-to-creatinine ratios (ACR) are associated with poor outcomes in cancer patients
Zhao, H., Li, X., Liu, X., Liu, C., Liu, C., Zheng, X., Chen, Y., Shi, J., Liu, Q., Bu, Z., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13480-x · Cited by 2
Nishiguchi, R., Shimakawa, T., Asaka, S., Ogawa, M., Sagawa, M., Kuhara, K., Usui, T., Yokomizo, H., & Shiozawa, S. (2025) · Surgery Today · doi:10.1007/s00595-025-03093-z · Cited by 2
Pagnotti, G. M., Trivedi, T., Wright, L. E., John, S. K., Murthy, S., Pattyn, R., Willis, M. S., She, Y., Suresh, S., Touray, A. F., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68522-0 · Cited by 2
Ahn, S. G., Sim, S., Kang, T., Kim, E., Lee, J. E., Moon, H., Ahn, J. H., Lim, W., Youn, H. J., Kim, H.-A., et al. (2026) · Journal of Breast Cancer · doi:10.4048/jbc.2025.0181 · Cited by 2
“Asian women generally have a lower body mass index (BMI), whereas a high BMI or obesity is associated with poorer breast-cancer outcomes [27-29].”
Nechalová, L., Penesová, A., Hric, I., Olej, P., Šimiaková, M., Ugrayová, S., Hekkala, J., Kelčíková, S., Grendár, M., Pekkala, S., et al. (2026) · Cancer Reports · doi:10.1002/cnr2.70611 · Cited by 2
Breast Cancer Prevention: Can Women's Expectations Be Met?
Ponzone, R. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0169 · Cited by 2
Otyłość a ryzyko rozwoju cukrzycy typu 2 i niektórych nowotworów złośliwych
Karnafel, W., & Możejko-Pastewka, B. (2015) · Clinical Diabetology · doi:10.5603/dk.2015.0018 · Cited by 2
“53) compared to people of normal body weight [64].”
BackgroundDiet and exercise in cancer: Epidemiologic perspectives on optimizing survivorship via lifestyle
Kenfield, S. A., Blarigan, E. L. V., Stampfer, M. J., & Chan, J. M. (2017) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2017.03.016 · Cited by 2
Barros, N. E. R. P., Bernhard, M. C. C., Carioca, A. A. F., Damasceno, N. R. T., & Verde, S. M. M. L. (2015) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2015v61n3.252 · Cited by 2
OBESITY AND BREAST CANCER: ADIPOKINES’ ROLE
de Freitas, E. D., & Rêgo, M. A. V. (2017) · Mastology · doi:10.29289/2594539420170000249 · Cited by 2
Эпидемия «нестероидной триады» (ожирение, диабет, метаболический синдром) и рак молочной железы
Берштейн, Л. М. (2018) · Malignant tumours · Cited by 2
Pantelimon, I., & Tebeică, T. (2019) · Oncolog-Hematolog ro · doi:10.26416/onhe.48.3.2019.2563 · Cited by 2
Immunohistochemical Expression of Leptin in Mammary Carcinoma
YASMINE F. ELESAWY, M. D. ;. R. M. R., & Amer, S. I. I. (2021) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2021.153810 · Cited by 2
Unintentional Weight Loss as a Marker of Malignancy Across Body Weight Categories
Hue, J. J., Ufholz, K. E., Winter, J. M., & Markt, S. C. (2021) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-021-00674-8 · Cited by 2
Genetic variation in adiposity related genes and risk for breast cancer in postmenopausal women
Fawzy, A., gomaa, A., aldaly, M., Hefzi, N., & nawzr, N. (2021) · Zagazig University Medical Journal · doi:10.21608/zumj.2021.88030.2298 · Cited by 2
Son, S., Lee, C., Lee, J. Y., Yang, D. S., & Kim, C. R. (2020) · The Journal of Korean Physical Therapy · doi:10.18857/jkpt.2020.32.3.177 · Cited by 2
da Cruz, L. A. P. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.22.2016.tde-04082016-195127 · Cited by 2
van den Berg, M. M. G. A. (2017) · doi:10.18174/423145 · Cited by 2
Su, Y., & Zheng, X. (2020) · doi:10.21203/rs.3.rs-44882/v2 · Cited by 2
“Besides well-known molecular subtypes,obesity is also an independent prognostic factor for breast cancer patients[24],which would cause a shorter OS and a worse distant recurrence-free survival[25].”
BackgroundEstrogen–progestin use and breast cancer characteristics in lean and overweight postmenopausal women
Kjartansdottir, O. J., Sigurðardóttir, L. G., Ólafsdóttir, E. J., Jonasson, J. G., Ursin, G., & Tryggvadóttír, L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4171-2 · Cited by 1
Golubnitschaja, O., Žúbor, P., Polívka, J., Smokovski, I., Gondova, A., Kasajová, P., Danko, J., Risteski, M., Trog, D., Konieczka, K., et al. (2019) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-030-13550-8_13 · Cited by 1
The Effect of Body Mass Index on Survival in Breast Cancer
Morsy, A., & Shehata, S. (2019) · Journal of Cancer Therapy · doi:10.4236/jct.2019.1012075 · Cited by 1
“53) women [26], similar results were found by Niraula et al.”
ResultDuderstadt, E. L., & Samuelson, D. J. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac288 · Cited by 1
Erdoğdu, B., & Utkan, G. (2023) · The European Research Journal · doi:10.18621/eurj.1099886 · Cited by 1
ŞAHİN, Y. Ç., & YILMAZ, S. (2023) · Journal of Contemporary Medicine · doi:10.16899/jcm.1350836 · Cited by 1
Early Survivorship: Rehabilitation and Reintegration
Kechagioglou, P., & Fuller-Shavel, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-51216-2_14 · Cited by 1
Mammographic features differ with body composition in women with breast cancer
Sartor, H., Sturesdotter, L., Larsson, A.-M., Rosendahl, A. H., & Zackrisson, S. (2024) · European Radiology · doi:10.1007/s00330-024-10937-8 · Cited by 1
“A previous review analyzed 82 studies and concluded that obesity was associated with impaired overall survival, as well as BC-speci fi c survival in both pre-and post-menopausal women with BC [5].”
Hoobler, R., Puklin, L. S., Harrigan, M., Cartmel, B., Li, F., Sanft, T. B., Ferrucci, L. M., Irwin, M. L., & Playdon, M. C. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01702-3 · Cited by 1
Lack of fibro-inflammatory response in human mammary adipose tissue in obesity
Fallone, F., Rebeaud, M., Bouche, C., Fontaine, J., Arellano, C., Ducoux‐Petit, M., Orgerit, L., Deudon, R., Nicolle, R., Franchet, C., et al. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01705-1 · Cited by 1
Verschure-Dorsman, S., Joe, S. T. A., Stuiver, M. M., & de Ligt, K. M. (2025) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2025.102841 · Cited by 1
Ennour‐Idrissi, K., Laforest, S., Tchernof, A., Durocher, F., & Diorio, C. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01814-5 · Cited by 1
Hernandez, A., Puppala, A., Hedlich-Dwyer, J., Mukherjee, N., Zhai, G., Zotto, V. L. D., Ning, B., Guo, H., Aneja, R., & Gassman, N. R. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02075-w · Cited by 1
“Obesity is recognized as a risk factor for post-menopausal breast cancer and is associated with poor survival, regardless of menopausal status [5, 6].”
Trenou, K. C., Mésidor, M., Eslami, A., Nabi, H., Diorio, C., & Talbot, D. C. (2025) · Biometrical Journal · doi:10.1002/bimj.70068 · Cited by 1
Oruç, A. F., Erol, M., Şahin, Ö., Eryılmaz, M. K., Araz, M., & Artaç, M. (2025) · Current Oncology · doi:10.3390/curroncol32090510 · Cited by 1
“Although it has been shown to negatively affect survival in early-stage breast cancer, studies have found that being overweight and obese are not associated with poorer outcomes in women with metastatic disease [5–7].”
Antioxidants and Metabolic Biomarkers: Clinical Insights in Breast Cancer Patients
Kareem, R., Yousif, E. A., Salman, T., & Bufaroosha, M. (2025) · AUIQ technical engineering science. · doi:10.70645/3078-3437.1047 · Cited by 1
The role of body mass index at diagnosis in patients with inflammatory breast cancer
Borremans, K., Nguyen, H.-L., Schepper, M. D., Lerebours, F., Vion, R., Clatot, F., Berghian, A., Maetens, M., Isnaldi, E., Molinelli, C., et al. (2025) · The Breast · doi:10.1016/j.breast.2025.104599 · Cited by 1
“In studies across breast cancer stages, patients with obesity have worse outcomes with lower rates of breast-cancer-specific survival and OS than patients without obesity [21,22].”
Weight change and diabetes risk following breast cancer: a nationwide cohort study
Jung, W., Jung, J.-H., Cho, I. Y., Yu, J., Baek, J.-H., Han, K., Park, Y., & Shin, D. W. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01898-y · Cited by 1
“[6, 7] However, weight gain of 1–5 kg following a breast cancer diagnosis is common [8, 9].”
Pierro, E. W., Garcia, G., Sanchez, V. M., Ericsson, P. I. G., Fingleton, B., Hasty, A. H., & Rexer, B. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-22614-x · Cited by 1
Associations between modifiable factors and early-onset breast cancer mortality among patients
Rantala, J., Seppä, K., Eriksson, J. G., Heinävaara, S. H., Härkänen, T., Jousilahti, P., Knekt, P., Koskinen, S. V. P., Laaksonen, M. A., Malila, N. K., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-15226-1 · Cited by 1
“Significantly increased BCSM was also seen in overweight patients, but the study did not stratify by menopausal status within this patient group [38].”
Martin, É., Meglio, A. D., Maccarone, S., Pistilli, B., Vanlemmens, L., Ségura, C., Bouleuc, C., Trédan, O., Crane, T. E., Soldato, D., et al. (2025) · European Journal of Cancer Care · doi:10.1155/ecc/5589906 · Cited by 1
“In addition to representing a risk factor for cancer-related fatigue and quality of life deterioration, obesity has been linked to several adverse outcomes among cancer survivors, including an increased overall and breast cancer specifc mortality rate after breast-cancer diagnosis [17–19].”
Holt-Kedde, I. L., Sadok, N., Kuikhoven, M., Schöder, C. P., Arjaans, M., Werker, P. M. N., & Viddeleer, A. R. (2026) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000012881 · Cited by 1
Holt-Kedde, I. L., Timmer‐Bosscha, H., Kruyt, F. A. E., Kelder, W., van der Vegt, B., Zwager, M. C., Schröder, C. P., & Arjaans, M. (2026) · Cancers · doi:10.3390/cancers18050868 · Cited by 1
Wang, J., Zhang, D., Zhang, Y., Wu, N., Yu, H., Guan, Y., Fan, Z., Liu, Y., & Jin, F. (2026) · Translational Breast Cancer Research · doi:10.21037/tbcr-2025-1-64 · Cited by 1
Hundal, J., Chen, J., Russell, K. B., Carfang, L., Bedeau, A. J., Giguère, L., Ouattara, M. M., Sehabi, G., Lebel, S., Shen, S., et al. (2026) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-26-517396 · Cited by 1
Temporal dynamics of prognostic factors in breast cancer survival
Tvete, I. F., & Klemp, M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0349115 · Cited by 1
“Overweight and obesity have been associated with poor prognosis and both overall and BC specific mortality, both for pre-and post-menopausal BC [10–12], partially mediated by tumor characteristics [13–14], although the literature is not unified [15].”
Günaltılı, M., Guliyev, M., Birsin, Z., Çerme, E., Aliyev, V., Şen, G. A., Güren, A. K., Özge, E., Gültürk, İ., Çolak, R., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-58205-7 · Cited by 1
“Meta-analyses and large cohort studies have shown that obesity is associated with higher risk of recurrence and decreased disease-free and overall survival 25–28 .”
Pagliuca, M., Buonaiuto, R., Verrazzo, A., Parola, S., Tafuro, M., Calderaio, C., Martinelli, C., Rienzo, R. D., Pirolo, M., Zurlo, C., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1840152 · Cited by 1
Burešová, I., Květoň, P., Jelínek, M., Halámková, J., Kišš, I., Hrnčiříková, I., & Kapounková, K. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04565-1 · Cited by 1
“However, BMI have been consistently associated in the literature with less favorable outcomes in breast cancer survivors [66], particularly in terms of recurrence risk and metabolic health.”
Crespo-Garcia, C., Borsati, A., Taaffe, D. R., Peddle‐McIntyre, C. J., Campbell, J. P., Avancini, A., Jeffery, E., Galvao, D. A., & Newton, R. U. (2026) · Sports Medicine · doi:10.1007/s40279-026-02481-w · Cited by 1
Mei, H., Yue, W., Zhang, L., & Huang, S. (2026) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2026.103249 · Cited by 1
Hundal, J., Linz, M. O., Anikreddy, S., Sengupta, S., Zhou, K., & Maiti, B. (2026) · JCO Oncology Practice · doi:10.1200/op-26-00061 · Cited by 1
Closing the recapitulation gap in obesity-conditioned TNBC drug development
Budhwani, K. I., Stringer-Reasor, E. M., Sorace, A. G., Buchsbaum, D. J., & Crawford, C. L. (2026) · npj Drug Discovery. · doi:10.1038/s44386-026-00074-1 · Cited by 1
“Epide-miologically, higher body mass index (BMI) has been associated with worse TNBC outcomes, including lower pathologic complete response, shorter disease-free and overall survival, and higher recurrence; broader breastcancersurvivalliteraturealsosupportsaBMIdoserelationship 14,17,18 .”
Prognosefaktoren gynäkologischer Malignome
van Mackelenbergh, M., & Mundhenke, C. (2015) · Der Gynäkologe · doi:10.1007/s00129-015-3795-8 · Cited by 1
Pederson, H. J., & Klemp, J. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00085-4 · Cited by 1
Okonji, D. O., & Ring, A. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-41858-2_1 · Cited by 1
The Role of Diet, Weight Control and Physical Activity in Breast Cancer Survivors
Buckland, G., Travier, N., & Agudo, A. (2014) · Breast Cancer Management · doi:10.2217/bmt.14.38 · Cited by 1
Morales, J. S., Lucía, A., & Pareja-Galeano, H. (2016) · ABACUS. Repositorio de Producción Científica (Universidad Europea) · Cited by 1
Lebensstilfaktoren und Komplementärmedizin beim Mammakarzinom
Voiß, P., Dobos, G. J., Choi, K., Lange, S., Kümmel, S., & Paul, A. (2017) · Der Gynäkologe · doi:10.1007/s00129-017-4067-6 · Cited by 1
Mwachofi, A., & Needell, L. (2017) · Journal of Diabetes and Obesity · doi:10.15436/2376-0494.17.1494 · Cited by 1
“However, breast cancer patients who are overweight or obese have higher mortality riskthan lean individual[6].”
BackgroundDiet, Physical Activity, and Weight Control for Cancer Patients and Survivors
Demark‐Wahnefried, W., Rogers, L. Q., Alfano, C. M., Thomson, C. A., Courneya, K. S., Meyerhardt, J. A., Stout, N. L., Kvale, E. A., Ganzer, H., Gansler, T. S., et al. (2017) · Wiley eBooks · doi:10.1002/9781119468868.ch23 · Cited by 1
Pre-diagnostic changes in body mass index and mortality among breast cancer patients
Larsen, S. B., Torstensson, M., Kenborg, L., Christensen, J., Kroman, N. T., Dalton, S. O., Tjønneland, A. M., Johansen, C., & Bidstrup, P. E. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4771-5 · Cited by 1
Mohammad, H., Bondarenko, I., Завізіон, В. Ф., Artemenko, M. V., Hojouj, T. V., Bondarenko, Y. N., Solovіovа, N. E., & Shevchenko, Y. A. (2018) · Medicni perspektivi · doi:10.26641/2307-0404.2018.1.124953 · Cited by 1
RELATIONSHIP BETWEEN OBESITY AND BREAST CANCER
Bello, P. P. D., Coelho, C. C. R., Rapatoni, L., & Peria, F. M. (2018) · Mastology · doi:10.29289/z2594539420180000196 · Cited by 1
Bi, K., Давыдов, С. О., & Stepanov, А. V. (2018) · Успехи физиологических наук · doi:10.7868/s0301179818040057 · Cited by 1
The influence of risk factors associated with lifestyle on the development of breast cancer
Szeja, N., & Słoma-Krześlak, M. (2019) · Oncoreview · doi:10.24292/01.or.030119 · Cited by 1
Einfluss von körperlicher Aktivität und Adipositas auf Inzidenz und Prognose gynäkologischer Tumoren
Dieterich, M., Gerber, B., & Stubert, J. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-4461-3 · Cited by 1
YeongKyong, O., & Hwang, S. Y. (2017) · Journal of the Korea Academia-Industrial cooperation Society · doi:10.5762/kais.2017.18.3.105 · Cited by 1
“이처럼 연령에 따라 대상자를 그룹화한 후 하위그룹 내 에서 비만이 유방암 환자의 예후에 영향을 주는지를 확 인하는 방법을 통해 Pierobon et al[13]이나 Chan et al[14]의 연구에서 폐경 후의 여성에게는 비만이 유방암 발생률이나 생존율에 영향을 미친다는 내용과 유사한 결 과를 확인할 수 있었다.”
Neues aus der S3-Leitlinie Mammakarzinom
Herbert, S.-L., Stüber, T. N., Diessner, J., & Wöckel, A. (2019) · CME · doi:10.1007/s11298-019-7098-6 · Cited by 1
Effects of breast cancer treatment on metabolic health
Sagarra‐Romero, L. (2020) · The Breast Journal · doi:10.1111/tbj.13852 · Cited by 1
(2020) · Journal of Virology and Mycology · doi:10.29011/2688-8750.100018 · Cited by 1
Benedetto, C., Canuto, E. M., & Borella, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00023-1 · Cited by 1
Effects of leptin on the viability of MCF-7 and T47D cells at different glucose concentrations.
Demırel, P. B., Doğan, S., Özorhan, Ü., Tuna, B. G., Schuster, T. F., & Cleary, M. P. (2020) · Journal of Experimental and Clinical Medicine · Cited by 1
Lee, J. S. (2020) · Journal of Breast Disease · doi:10.14449/jbd.2020.8.2.108 · Cited by 1
Is BMI a Factor in Compliance to Adjuvant Chemotherapy for Locally Advanced Rectal Cancer?
Mari, G. M., Crippa, J., Achilli, P., Maggioni, D., Costanzi, A., Scotti, M. A., Braga, M., Cocozza, E., Borroni, G., Benzoni, I., et al. (2021) · Chirurgia · doi:10.21614/chirurgia.116.1.51 · Cited by 1
“The association between obesity and oncological outcomes has been investigated in other types of cancer, and was found to be associated with higher rates of local recurrence, distant metastasis, and decreased overall survival (14,15).”
BackgroundBilginer, M. C., & Kavgacı, H. (2021) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.880502 · Cited by 1
Present Options in the Prevention of Breast Cancer
Russo, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-72815-1_7 · Cited by 1
Moukal, A., Farouqi, A. E., Aghrouch, M., EL-Bakraoui, K., Zekhnini, A., & Izaabel, E. H. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2294 · Cited by 1
OBESITY AND ITS RELATIONSHIP WITH CANCER: PART III
Agarwal, S. K. (2021) · American International Journal of Cancer Studies · doi:10.46545/aijcs.v3i1.218 · Cited by 1
Khamis, A. A., Ibrahim, R. M., El-Hefnawy, G. B., Ibrahim, W. M., & Ali, E. M. M. (2022) · Genes & Nutrition · doi:10.1186/s12263-022-00709-8 · Cited by 1
“The results correlated with a previous study [39] where there was a decrease in the tumor size and body weight of mice.”
ResultCancer patients’ constitutional features as a predictor of the efficiency of immunotherapy
Дмитриев, В. Н., Lyadov, V. K., Lyadova, M. A., & Шаманов, А. В. (2022) · P A Herzen Journal of Oncology · doi:10.17116/onkolog20221103157 · Cited by 1
Contoli, B., Possenti, V., Minardi, V., Gori, S., Beretta, G. D., & Masocco, M. (2022) · Cancers · doi:10.3390/cancers14246185 · Cited by 1
Polat, H. T., & Serin, E. K. (2022) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2021-87518 · Cited by 1
Haynam, M. L., Chaplow, Z. L., DeScenza, V. R., Bowman, J. D., Dispennette, K., Zhang, X., Kilar, M., Hohn, S., Fairman, C. M., Lustberg, M. B., et al. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101154 · Cited by 1
Estado nutricional pré e pós-quimioterapia em mulheres com câncer de mama: Uma revisão sistemática
Pereira, M. M. L., Silvino, V. O., Sousa, B. L. S. C., Magalhães, M. T. D. J. F. M., de Moura, R. C., LIMA, I. M. O. M., da Silva, M. S., & dos Santos, M. A. P. (2023) · Revista Contexto & Saúde · doi:10.21527/2176-7114.2023.47.13038 · Cited by 1
Armașu, I. (2023) · The Medical-Surgical Journal · doi:10.22551/msj.2023.02.03 · Cited by 1
Pila, E., Sabiston, C. M., Christensen, R. A. G., Huellemann, K. L., Hallward, L., Taylor, V. H., Arbour‐Nicitopoulos, K. P., & Wharton, S. (2023) · Psychology and Health · doi:10.1080/08870446.2023.2247426 · Cited by 1
“…be diagnosed with breast cancer (Eliassen et al., 2006), have a more advanced stage at diagnosis (Reeves et al., 2007), have a higher risk of recurrence (Chan et al., 2014), and have higher rates of cancer-related mortality, compared to women in other weight classifications (Harborg et al., 2021;…”
Adipose Compounds in Breast Tumor Extracellular Matrix
Piccioni, F., & Luca, P. D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_12 · Cited by 1
Dalkır, K. A., Mirioğlu, A., Kundakçı, B., Bağır, M., DEVECİ, M. A., & Özbarlas, H. S. (2024) · Acta Orthopaedica et Traumatologica Turcica · doi:10.5152/j.aott.2024.23132 · Cited by 1
McFarland, B. J., Xiao, E., Chen, L., Xu, R., & Wang, X. (2024) · International Workshop on Breast Imaging (IWBI) · doi:10.1117/12.3027051 · Cited by 1
An Investigation on Breast Cancer Knowledge in Developing Nations
Kagita, U. S. (2024) · International Journal of Indigenous Herbs and Drugs · doi:10.46956/ijihd.v9i2.624 · Cited by 1
Chen, S., Borch, K. B., Sandanger, T. M., Tinmouth, J., Braaten, T., & Nøst, T. H. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083594 · Cited by 1
“BMI, Body Mass Index; HRT, hormone replacement therapy; OC, oral contraceptive; SEER, Surveillance, Epidemiology and End Results; TNM, tumour, node and metastasis.”
Influential
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.